This topic contains a solution. Click here to go to the answer

Author Question: While assessing a patient prior to the administration of neostigmine (Prostigmine) for the treatment ... (Read 16 times)

wenmo

  • Hero Member
  • *****
  • Posts: 540
While assessing a patient prior to the administration of neostigmine (Prostigmine) for the treatment of myasthenia gravis, a nurse notices that the patient has greater muscle strength than when assessed 1 hour ago.
 
  The nurse's interpretation of this assessment information is that
  a. the dose needs to be increased.
  b. the medication schedule seems to be effective.
  c. the patient will not require the next scheduled dose.
  d. toxicity is impending.

Question 2

A patient is admitted to the unit with complaints of abdominal pain and a history of myasthenia gravis. During the health history the nurse determines that the patient has been taking neostigmine (Prostigmin).
 
  The nurse should further assess the patient for
  a. bradycardia, diaphoresis, and urinary urgency.
  b. tachycardia, diaphoresis, and urinary retention.
  c. xerostomia, diaphoresis, and mydriasis.
  d. increased gastric motility, mydriasis, and urinary retention.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kescobar@64

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

ANS: B
Important signs of improvement for patients with myasthenia gravis are ease of swallowing and increased ability to raise the eyelids. Increased muscle strength is the desired effect.
There is no indication that the dose needs to be increased. In fact, if the dosage is increased, this could lead the patient to develop a cholinergic crisis.
The patient should continue taking this dose as ordered, because it is producing the desired effect.
The patient is not exhibiting any signs or symptoms of toxicity.

Answer to Question 2

ANS: A
Accumulation of acetylcholine, seen in patients with myasthenia gravis, results in bradycardia, diaphoresis, and urinary urgency. These assessment findings are also a result of the adverse effects of neostigmine.
Tachycardia and urinary retention are not adverse effects of excessive muscarinic stimulation.
Xerostomia and mydriasis are not adverse effects of neostigmine or an accumulation of acetylcholine.
Increased gastric motility, mydriasis, and urinary retention are not adverse effects of neostigmine or an accumulation of acetylcholine.




wenmo

  • Member
  • Posts: 540
Reply 2 on: Jul 23, 2018
:D TYSM


billybob123

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

For a complete list of videos, visit our video library